Latest News & Updates

Breaking News

  • 2 hours ago

  • Vaibhavi M.

Kane Biotech Restarts North American Sales Of Revyve® Wound Gel, Appoints Business Development Leaders
Breaking News
SEOPRO Sets New Benchmark for AI-Driven Pharma Project & Portfolio Management

Team Pharma Now

Roche’s Phase III MAJESTY Study Shows Gazyva Superior To Tacrolimus In Primary Membranous Nephropathy

Vaibhavi M.

Oncotelic And Sapu Bioscience Expand Global IP Protection For OT-101 Across CNS And Oncology

Vaibhavi M.

Cue Biopharma Appoints Lucinda Warren To Chief Financial And Business Officer, Strengthening Financial And Strategic Leadership

Vaibhavi M.

Other trending news you may like to read

Kane Biotech Restarts North American Sales Of Revyve® Wound Gel, Appoints Business Development Leaders

Kane Biotech resumes North American sales of revyve® wound gel and names new business development leaders.

Vaibhavi M.

Pharma Now

SEOPRO Sets New Benchmark for AI-Driven Pharma Project & Portfolio Management

SEOPRO: the first AI-Driven pharma project & portfolio management platform developed by Seosaph Infotech secures strong industry endorsement

Team Pharma Now

Pharma Now

Roche’s Phase III MAJESTY Study Shows Gazyva Superior To Tacrolimus In Primary Membranous Nephropathy

Roche’s Phase III MAJESTY trial shows Gazyva outperforms tacrolimus in primary membranous nephropathy.

Vaibhavi M.

Pharma Now

Oncotelic And Sapu Bioscience Expand Global IP Protection For OT-101 Across CNS And Oncology

Oncotelic and Sapu expand global IP protection for OT-101 across CNS, oncology, and drug delivery technologies.

Vaibhavi M.

Pharma Now